Spherix Closes Registered Direct Offering Of $1.15 Million In Common Stock And Warrants
Spherix has entered into definitive agreements to sell $1.15 million of shares of its common stock and warrants.
Spherix has entered into definitive agreements to sell $1.15 million of shares of its common stock and warrants.
OneMedPlace announced today that its “OneMedForum 2011” business development and finance conference for emerging healthcare and life science companies will be held January 11-13, 2011, in San Francisco at the Sir Francis Drake Hotel.
Shares in Spherix shot up by 77 percent after the biotechnology company announced preliminary Phase III results for its Type 2 diabetes drug candidate.
Copyright © 2024 | WordPress Theme by MH Themes